It’s Editor’s Picks time at the end of the year, which is a sure sign that your local journalists are looking to stick something on the site you can read during a slow week so we can spend time with our families.
Seriously, this has been a fascinating and typically frenzied year for us at Xconomy Seattle. The biggest story for me personally has been the hiring of our new senior editor Curt Woodward. I introduced him in these pages as “one of the best all-around reporters in our state” when he joined us in mid-February, and he has delivered the goods on the local technology beat. You can see for yourself by checking out Curt’s 2012 preview story, which ran yesterday.
The other significant news for us is that we are planning to move into new digs in early 2012, at 1551 Eastlake Avenue East, the former headquarters of the Bill & Melinda Gates Foundation. Curt and I are psyched about this move into the high-rent district, from our (cough, cough) humble startup abode. We are looking forward to inviting readers over for a happy hour/open house once we are settled in, probably sometime in February.
With that, I thought it would be worth reflecting a bit on the biggest life sciences stories of the year in Seattle. These aren’t necessarily the biggest traffic generators, or the biggest earth-shaking events of the year. Instead, these picks represent the kind of original, in-depth coverage that we believe makes us a must-read for news and analysis in the local innovation community. These are my personal favorites from the biotech side of this operation in 2011—see Curt’s story to get a feel for his faves on the tech beat.
As always, if you have ideas of interesting people and companies that I should check out, just send me a note at [email protected]. See you out there in biotechland in 2012. And above all, thank you for reading.
“Dendreon Wounds are Self-Inflicted, Not the Start of a Biotech Industry Virus“
“Lady Gaga’s Favorite Seattle Tech Startup, Clarisonic, Cracks Big-Time With $100M Sales“
“Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies“
“How ZymoGenetics Coulda Been a Contender: The Big Break That Came Too Late“
“Ken Stuart, the Working Class Kid Who Built a Global Health Hotspot at Seattle Biomed“
“Seattle Genetics: The Next Big Litmus Test for High-Priced Cancer Drugs“
“NanoString Nails Breast Cancer Prognosis Study, Challenging Genomic Health“
“Exclusive: Pathway Medical Technologies to be Acquired by Bayer’s Medrad Unit for $125M“
“Light Sciences Oncology Stumbles in Clinical Trial, Layoffs Loom“
“Mobisante Wins FDA Approval for Ultrasound on a Smartphone Technology“
“Blaze Bioscience, Fred Hutch Spinoff With Zymo Vet at the Helm, Seeks to Paint Tumors“
“The Immunex Alumni: Where Are They Now?“
